Register entry
Lyophilization Services of New England, Inc. (LSNE) D/B/A: PCI Pharma Services
Data as of · How to read this entry
- Registered sites
- 1
- Active NDC listings
- 0
- Live patents
- 0
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
Analytical testing1Labelling1Finished drug manufacture1Packaging1Repackaging1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Lyophilization Services of New England, Inc. (LSNE), D/B/A: PCI Pharma ServicesRegistrant: Lyophilization Services of New England, Inc. (LSNE) D/B/A: PCI Pharma Services | 29B Commerce Drive, Bedford, New Hampshire (NH) 03110, United States (USA) | Analytical testing, Labelling, Finished drug manufacture, Packaging, Repackaging | 3008546445119018241 |
Compare
Comparable companies in United States
- Hahnemann Laboratories, Inc. dba Alpine Pharmaceuticals1 site · 4,853 NDC
- NuCare Pharmaceuticals,Inc.1 site · 1,393 NDC
- Greer Laboratories, Inc.1 site · 1,328 NDC
- ASCLEMED USA INC. DBA ENOVACHEM1 site · 789 NDC
- Golden State Medical Supply Inc.1 site · 670 NDC
- Rising Pharma Holdings, Inc.1 site · 532 NDC
- HF Acquisition Co LLC1 site · 363 NDC
- ANI Pharmaceuticals, Inc.1 site · 299 NDC
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.1 site · 273 NDC
- Newton Laboratories, Inc.1 site · 271 NDC
Enquiry
Common questions
- Is Lyophilization Services of New England, Inc. (LSNE) D/B/A: PCI Pharma Services FDA approved?
- Lyophilization Services of New England, Inc. (LSNE) D/B/A: PCI Pharma Services holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Lyophilization Services of New England, Inc. (LSNE) D/B/A: PCI Pharma Services's drugs manufactured?
- The FDA register lists Bedford, NH. Registered operations: analytical testing, labelling, finished drug manufacture, packaging, repackaging.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.